Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
October 23, 2002
Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway
Fabien Schmidlin, Silvia Amadesi, Karim Dabbagh, et al.
Plos One
|
June 4, 2020
Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis
Bernat Baeza-Raja, Andrew Goodyear, Xiao Liu, et al.
Frontiers in Microbiology
|
December 21, 2020
A Comparative Evaluation of Tools to Predict Metabolite Profiles From Microbiome Sequencing Data
Xiaochen Yin, Tomer Altman, Erica Rutherford, et al.
Plos Biology
|
January 21, 2015
Where next for microbiome research?
Matthew K Waldor, Gene Tyson, Elhanan Borenstein, et al.
Frontiers in Microbiology
|
October 31, 2022
Strain level and comprehensive microbiome analysis in inflammatory bowel disease <i>via</i> multi-technology meta-analysis identifies key bacterial influencers of disease
Jayamary Divya Ravichandar, Erica Rutherford, Cheryl-Emiliane T Chow, et al.
Gut Microbes
|
January 15, 2025
Host-microbe multi-omics and succinotype profiling have prognostic value for future relapse in patients with inflammatory bowel disease
Jill O'Sullivan, Shriram Patel, Gabriel E Leventhal, et al.
Physiological Genomics
|
March 30, 2006
Genetic segregation of airway disease traits despite redundancy of calcium-activated chloride channel family members
Anand C Patel, Jeffrey D Morton, Edy Y Kim, et al.
Scientific Reports
|
October 11, 2022
Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups
Kiana A West, Xiaochen Yin, Erica M Rutherford, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 9, 2008
Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity
Ronald J Hill, Karim Dabbagh, Deborah Phippard, et al.
Blood
|
March 3, 2010
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
Ekkehard Mössner, Peter Brünker, Samuel Moser, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of Immunology (Baltimore, Md. : 1950)
|
October 23, 2002
Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway
Fabien Schmidlin, Silvia Amadesi, Karim Dabbagh, et al.
Plos One
|
June 4, 2020
Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis
Bernat Baeza-Raja, Andrew Goodyear, Xiao Liu, et al.
Frontiers in Microbiology
|
December 21, 2020
A Comparative Evaluation of Tools to Predict Metabolite Profiles From Microbiome Sequencing Data
Xiaochen Yin, Tomer Altman, Erica Rutherford, et al.
Plos Biology
|
January 21, 2015
Where next for microbiome research?
Matthew K Waldor, Gene Tyson, Elhanan Borenstein, et al.
Frontiers in Microbiology
|
October 31, 2022
Strain level and comprehensive microbiome analysis in inflammatory bowel disease <i>via</i> multi-technology meta-analysis identifies key bacterial influencers of disease
Jayamary Divya Ravichandar, Erica Rutherford, Cheryl-Emiliane T Chow, et al.
Gut Microbes
|
January 15, 2025
Host-microbe multi-omics and succinotype profiling have prognostic value for future relapse in patients with inflammatory bowel disease
Jill O'Sullivan, Shriram Patel, Gabriel E Leventhal, et al.
Physiological Genomics
|
March 30, 2006
Genetic segregation of airway disease traits despite redundancy of calcium-activated chloride channel family members
Anand C Patel, Jeffrey D Morton, Edy Y Kim, et al.
Scientific Reports
|
October 11, 2022
Multi-angle meta-analysis of the gut microbiome in Autism Spectrum Disorder: a step toward understanding patient subgroups
Kiana A West, Xiaochen Yin, Erica M Rutherford, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 9, 2008
Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity
Ronald J Hill, Karim Dabbagh, Deborah Phippard, et al.
Blood
|
March 3, 2010
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
Ekkehard Mössner, Peter Brünker, Samuel Moser, et al.
Page
of 3